Patent · US Active

Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens

US10040826B2 · kind B2 · utility

0Cited by

9References

67Claims

0Family size

Assignees

Duke University · US
The United States of America as represented by the Secretary of the Army · US
Children's Medical Center Corporation · US

Inventors

Jerome Kim · Fort Detrick, US
Stephen C. Harrison · Cambridge, US
Barton F. Haynes · Durham, US
Georgia Tomaras · Durham, US
Nelson Michael · Fort Detrick, US

Key dates

Filing date	Jul 5, 2012
Grant date	Aug 7, 2018
Priority date	—
Expiry date	Sep 5, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/16134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.